Tectonic Therapeutic, Inc. (TECX)
(Delayed Data from NSDQ)
$16.06 USD
-0.16 (-0.99%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $16.06 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum C VGM
Price, Consensus and EPS Surprise
TECX 16.06 -0.16(-0.99%)
Will TECX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TECX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for TECX
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
Tectonic Therapeutic reports Q2 EPS ($4.34), consensus ($1.50)
Tectonic Therapeutic: Analyzing Its Post-Merger Valuation And Prospects
Analysts Have Conflicting Sentiments on These Healthcare Companies: Revvity (RVTY), PTC Therapeutics (PTCT) and Tectonic Therapeutic (TECX)
Leerink Partners Remains a Buy on Tectonic Therapeutic (TECX)